Chemically Modified Guide RNAs for Nuclease-Resistant CRISPR Editing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Oligonucleotides, particularly RNA, are prone to degradation by endonucleases and exonucleases, which compromises the stability and efficiency of guide RNAs in CRISPR/Cas systems, especially in therapeutic applications.
Innovation Solution
Modified guide RNAs with specific nucleotide modifications, such as 2′-O-methyl, 2′-O-(2-methoxyethyl), 2′-fluoro, phosphorothioate bonds, and G-C substitutions, are introduced to enhance stability and activity of guide RNA/Cas9 complexes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If guide RNA is used in CRISPR/Cas systems, then gene editing activity is achieved, but RNA degradation by endonucleases and exonucleases reduces stability and efficiency
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of nucleotides in guide RNA. Specifically, it introduces 2′-O-methyl modifications at positions 10-18 from the 5′ end and 2′-O-(2-methoxyethyl) modifications at positions 1-9 from the 5′ end. These chemical parameter changes alter the RNA's susceptibility to nucleolytic degradation, thereby extending its half-life and improving stability without compromising gene editing activity
Solution Approach 2:
The patent employs composite materials by combining different types of modified nucleotides within the guide RNA structure. The guide RNA contains a hybrid composition of 2′-O-methyl nucleotides (providing stability) and 2′-O-(2-methoxyethyl) nucleotides (providing enhanced resistance to degradation). This composite approach creates a guide RNA that balances stability and activity better than uniform modifications
2Duration of action of moving object
If RNA modifications are introduced to improve stability, then guide RNA half-life is extended, but complexity of RNA synthesis increases
Solution Approach 1:
The patent applies local quality by implementing modifications only in specific regions of the guide RNA rather than uniformly throughout. The 2′-O-methyl modifications are placed at positions 10-18 from the 5′ end (targeting the scaffold region), while 2′-O-(2-methoxyethyl) modifications are placed at positions 1-9 from the 5′ end (targeting the 5′ overhang region). This localized modification strategy improves stability while minimizing synthesis complexity compared to full-length modifications
Data Source
AI summary
This disclosure relates to modified single and dual guide RNAs having improved in vitro and in vivo activity in gene editing methods.


